Kathryn G Roberts Selected Research

Kathryn G Roberts Research Topics

Disease

37	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2024 - 02/2011
16	Leukemia 01/2023 - 02/2011
9	Philadelphia Chromosome 11/2021 - 09/2014
8	Neoplasms (Cancer) 01/2023 - 07/2010
8	Residual Neoplasm 01/2023 - 09/2014
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 07/2010
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 11/2023 - 01/2019
1	Turcot syndrome 03/2024
1	Trisomy (Trisomies) 12/2023
1	Lymphoma (Lymphomas) 12/2021
1	Inflammation (Inflammations) 11/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Glucocorticoid Receptor Deficiency 01/2020
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 09/2017
1	Polycythemia (Erythrocytosis) 02/2016
1	Hypersensitivity (Allergy) 02/2016
1	Hematologic Neoplasms (Hematological Malignancy) 01/2016
1	Systemic Mastocytosis 07/2010
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 07/2010

Drug/Important Bio-Agent (IBA)

9	Phosphotransferases (Kinase)IBA 12/2021 - 07/2010
7	Cytokine Receptors (Cytokine Receptor)IBA 11/2021 - 08/2012
6	Tyrosine Kinase InhibitorsIBA 11/2018 - 07/2010
5	Messenger RNA (mRNA)IBA 10/2022 - 01/2019
5	Transcription Factors (Transcription Factor)IBA 11/2021 - 09/2014
4	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 02/2011
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
3	Janus KinasesIBA 12/2021 - 02/2015
2	Asparaginase (Elspar)FDA Link 12/2023 - 01/2022
2	blinatumomabIBA 10/2022 - 01/2021
2	Oncogene Proteins (Oncogene Protein)IBA 01/2022 - 01/2021
2	venetoclaxIBA 01/2021 - 01/2020
2	MicroRNAs (MicroRNA)IBA 12/2020 - 01/2020
2	Protein Isoforms (Isoforms)IBA 09/2017 - 12/2016
2	Tyrosine (L-Tyrosine)FDA Link 02/2016 - 06/2015
1	Inotuzumab OzogamicinIBA 03/2024
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 12/2023
1	gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)IBA 11/2023
1	V 70 (V70)IBA 11/2023
1	HMGN1 Protein (HMGN1)IBA 01/2023
1	RNA Splicing FactorsIBA 12/2022
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 10/2022
1	Chimeric Antigen ReceptorsIBA 10/2022
1	hydrogen sulfite (bisulfite)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	ChromatinIBA 01/2022
1	Interleukin-7 (Interleukin 7)IBA 12/2021
1	Proteolysis Targeting ChimeraIBA 12/2021
1	Prednisone (Sone)FDA LinkGeneric 01/2021
1	navitoclaxIBA 01/2021
1	NucleotidesIBA 12/2020
1	Methotrexate (Mexate)FDA LinkGeneric 12/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2020
1	Prednisolone (Predate)FDA LinkGeneric 01/2020
1	Drug CombinationsIBA 01/2020
1	ProdrugsIBA 01/2019
1	nelarabine (506U78)FDA Link 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2018
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2018
1	Erythropoietin FDA Link 02/2016
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 02/2016
1	Ikaros Transcription FactorIBA 09/2015
1	RetinoidsIBA 09/2015
1	AZD 1480IBA 02/2015
1	Janus Kinase InhibitorsIBA 02/2015
1	Proteins (Proteins, Gene)FDA Link 09/2014
1	ruxolitinibIBA 10/2012
1	Sirolimus (Rapamycin)FDA Link 10/2012
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 07/2010
1	Fingolimod Hydrochloride (FTY720)FDA Link 07/2010
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2010
1	Imatinib Mesylate (Gleevec)FDA Link 07/2010
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 07/2010

Therapy/Procedure

11	Therapeutics 03/2024 - 09/2013
5	Drug Therapy (Chemotherapy) 03/2024 - 01/2017
4	Remission Induction 01/2022 - 09/2014
2	Immunotherapy 10/2022 - 01/2020
1	Stem Cell Transplantation 01/2021
1	Heterologous Transplantation (Xenotransplantation) 01/2020